Tekla Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Tekla Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-110,038	Closed	-$5.88M	–	165
2016 Q1	$5.88M	Hold	110,038	–	–	0.25%	76
2015 Q4	$12.4M	Buy	110,038 +44,638	+68%	+$4.92M	0.45%	47
2015 Q3	$7.7M	Buy	+65,400	New	+$8.54M	0.28%	80

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Tekla Capital Management's ANAC Position: Q2 2016 in Review

Tekla Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 110,038 shares — an estimated $5.88M sold.

Tekla Capital Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $12.4M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Tekla Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Tekla Capital Management sold 110,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.88M.
Tekla Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Tekla Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $12.4M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Tekla Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.